Antibodies : Engineering and Therapeutics

  • Therapeutic Abs come from critical screenings of in vivo and in vitromethods
  • Bispecific Abs increase specificity and broaden the range of therapeutic MOA.
  • Optimized Ab leads undergo HFA, affinity maturation, and developability assessment.
  • Fc optimization is critical for antibody pharmacokinetics and pharmacodynamics

Related Conference of Antibodies : Engineering and Therapeutics

July 27-28, 2018

31st Annual Congress on Vaccines, Clinical Trials & B2B

Vancouver, Canada
September 19-20, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
October 22-23, 2018

30th World Congress on Vaccines and Immunization

Osaka, Japan
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA

Antibodies : Engineering and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in